Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors (1976)

No AccessJournal of Urology1 Aug 1976Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors A. Morales, D. Eidinger, and A.W. Bruce A. MoralesA. Morales Current address: Laboratory of Immunodiagnosis, Building 8, Room 118, National Institutes of Health, Bethesda, Maryland, 20014. More articles by this author , D. EidingerD. Eidinger More articles by this author , and A.W. BruceA.W. Bruce More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)58737-6AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking. © 1976 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byDonin N, Lenis A, Holden S, Drakaki A, Pantuck A, Belldegrun A and Chamie K (2018) Immunotherapy for the Treatment of Urothelial CarcinomaJournal of Urology, VOL. 197, NO. 1, (14-22), Online publication date: 1-Jan-2017.Droller M (2016) Intracavitary bacillus Calmette-Guérin for Superficial Bladder TumorsJournal of Urology, VOL. 197, NO. 2S, (S146-S147), Online publication date: 1-Feb-2017.Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M, Tanaka H, Takahashi S, Tsushima T, Kanayama H, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T and Naito S (2018) Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder CancerJournal of Urology, VOL. 195, NO. 1, (41-46), Online publication date: 1-Jan-2016.Gan C, Amery S, Chatterton K, Khan M, Thomas K and O’Brien T (2018) Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year OutcomesJournal of Urology, VOL. 195, NO. 6, (1697-1703), Online publication date: 1-Jun-2016.Holmäng S (2018) Patients with High Grade Bladder Cancer, and Tumor-Free 3 and 6-Month Cystoscopy after bacillus Calmette-Guérin have a Good Prognosis without Further Maintenance bacillus Calmette-GuérinUrology Practice, VOL. 3, NO. 1, (50-54), Online publication date: 1-Jan-2016.Barlow L, McKiernan J and Benson M (2018) Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin TherapyJournal of Urology, VOL. 189, NO. 3, (834-839), Online publication date: 1-Mar-2013.Johnson M, Nepple K, Peck V, Trinkaus K, Klim A, Sandhu G and Kibel A (2018) Randomized Controlled Trial of Oxybutynin Extended Release Versus Placebo for Urinary Symptoms During Intravesical Bacillus Calmette-Guérin TreatmentJournal of Urology, VOL. 189, NO. 4, (1268-1274), Online publication date: 1-Apr-2013.Brausi M, Witjes J, Lamm D, Persad R, Palou J, Colombel M, Buckley R, Soloway M, Akaza H and Böhle A (2018) A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer GroupJournal of Urology, VOL. 186, NO. 6, (2158-2167), Online publication date: 1-Dec-2011.Alvarez-Múgica M, Cebrian V, Fernández-Gómez J, Fresno F, Escaf S and Sánchez-Carbayo M (2018) Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder CancerJournal of Urology, VOL. 184, NO. 4, (1507-1513), Online publication date: 1-Oct-2010.DeCastro G and Steinberg G (2018) Are We Making Significant Progress in the Diagnosis and Management of Bladder Cancer?Journal of Urology, VOL. 183, NO. 5, (1667-1668), Online publication date: 1-May-2010.Nepple K, Lightfoot A, Rosevear H, O'Donnell M and Lamm D (2018) Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder CancerJournal of Urology, VOL. 184, NO. 5, (1915-1919), Online publication date: 1-Nov-2010.Rosevear H, Lightfoot A, Nepple K and O'Donnell M (2018) Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic DevicesJournal of Urology, VOL. 184, NO. 5, (1920-1924), Online publication date: 1-Nov-2010.Bisiaux A, Thiounn N, Timsit M, Eladaoui A, Chang H, Mapes J, Mogenet A, Bresson J, Prié D, Béchet S, Baron C, Sadorge C, Thomas S, Albert E, Albert P and Albert M (2018) Molecular Analyte Profiling of the Early Events and Tissue Conditioning Following Intravesical Bacillus Calmette-Guerin Therapy in Patients With Superficial Bladder CancerJournal of Urology, VOL. 181, NO. 4, (1571-1580), Online publication date: 1-Apr-2009.Huang G, Hamilton A, Lo M, Stein J and Penson D (2018) Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care ProjectJournal of Urology, VOL. 180, NO. 2, (520-524), Online publication date: 1-Aug-2008.Herr H and Morales A (2018) History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success StoryJournal of Urology, VOL. 179, NO. 1, (53-56), Online publication date: 1-Jan-2008.Berglund R, Savage C, Vora K, Kurta J and Cronin A (2018) An Analysis of the Effect of Statin Use on the Efficacy of Bacillus Calmette-Guerin Treatment for Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 180, NO. 4, (1297-1300), Online publication date: 1-Oct-2008.Yu D, Lee C and Chang S (2018) Immunotherapy for Orthotopic Murine Bladder Cancer Using Bacillus Calmette-Guerin Recombinant Protein Mpt-64Journal of Urology, VOL. 177, NO. 2, (738-742), Online publication date: 1-Feb-2007.Smith E, Schwartz M, Kawamoto H, You X, Hwang D, Liu H and Scherr D (2018) Antitumor Effects of Imidazoquinolines in Urothelial Cell Carcinoma of the BladderJournal of Urology, VOL. 177, NO. 6, (2347-2351), Online publication date: 1-Jun-2007.Griffith T (2018) Predicting Bacillus Calmette-Guerin Immunotherapy EffectivenessJournal of Urology, VOL. 178, NO. 6, (2247-2248), Online publication date: 1-Dec-2007.Koya M, Simon M and Soloway M (2018) Complications of Intravesical Therapy for Urothelial Cancer of the BladderJournal of Urology, VOL. 175, NO. 6, (2004-2010), Online publication date: 1-Jun-2006.LEE C, CHANG S, HSIEH D and YU D (2018) Immunotherapy for Bladder Cancer Using Recombinant Bacillus Calmette-Guerin DNA Vaccines and Interleukin-12 DNA VaccineJournal of Urology, VOL. 171, NO. 3, (1343-1347), Online publication date: 1-Mar-2004.VOLKMER B, GSCHWEND J, MAIER S, SEIDL-SCHLICK E, BACH D and ROMICS I (2018) T2a Transitional Cell Carcinoma of the Bladder: Long-term Experience With Intravesical Immunoprophylaxis With Bacillus Calmette-guerinJournal of Urology, VOL. 169, NO. 3, (931-935), Online publication date: 1-Mar-2003.BİLEN C, İNCİ K, ERKAN İ and ÖZEN H (2018) The Predictive Value Of Purified Protein Derivative Results On Complications And Prognosis In Patients With Bladder Cancer Treated With Bacillus Calmette-GuerinJournal of Urology, VOL. 169, NO. 5, (1702-1705), Online publication date: 1-May-2003.PEYROMAURE M, GUERIN F, AMSELLEM-OUAZANA D, SAIGHI D, DEBRE B and ZERBIB M (2018) Intravesical Bacillus Calmette-Guerin Therapy for Stage T1 Grade 3 Transitional Cell Carcinoma of the Bladder: Recurrence, Progression and Survival in a Study of 57 PatientsJournal of Urology, VOL. 169, NO. 6, (2110-2112), Online publication date: 1-Jun-2003.BÖHLE A and BRANDAU S (2018) Immune Mechanisms in Bacillus Calmette-Guerin Immunotherapy for Superficial Bladder CancerJournal of Urology, VOL. 170, NO. 3, (964-969), Online publication date: 1-Sep-2003.SAINT F, PATARD J, MAILLE P, SOYEUX P, HOZNEK A, SALOMON L, ABBOU C and CHOPIN D (2018) PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCERJournal of Urology, VOL. 167, NO. 1, (364-367), Online publication date: 1-Jan-2002.THIOUNN N, PAGES F, MEJEAN A, DESCOTES J, FRIDMAN W and ROMET-LEMONNE J (2018) Adoptive Immunotherapy For Superficial Bladder Cancer With Autologous Macrophage Activated Killer CellsJournal of Urology, VOL. 168, NO. 6, (2373-2376), Online publication date: 1-Dec-2002.Chen F, Crist S, Zhang G, Iwamoto Y and See W (2018) Interleukin-6 Production by Human Bladder Tumor Cell Lines is Up-Regulated by Bacillus Calmette-Guerin Through Nuclear Factor-κB and Ap-1 Via an Immediate Early PathwayJournal of Urology, VOL. 168, NO. 2, (786-797), Online publication date: 1-Aug-2002.GRIFFITHS T, CHARLTON M, NEAL D and POWELL P (2018) Treatment of Carcinoma In Situ With Intravesical Bacillus Calmette-Guerin Without MaintenanceJournal of Urology, VOL. 167, NO. 6, (2408-2412), Online publication date: 1-Jun-2002.SAINT F, PATARD J, MAILLE P, SOYEUX P, HOZNEK A, SALOMON L, DE LA TAILLE A, ABBOU C and CHOPIN D (2018) T HELPER 1/2 LYMPHOCYTE URINARY CYTOKINE PROFILES IN RESPONDING AND NONRESPONDING PATIENTS AFTER 1 AND 2 COURSES OF BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL BLADDER CANCERJournal of Urology, VOL. 166, NO. 6, (2142-2147), Online publication date: 1-Dec-2001.MACK D, HÖLTL W, BASSI P, BRAUSI M, FERRARI P, de BALINCOURT C and SYLVESTER R (2018) THE ABLATIVE EFFECT OF QUARTER DOSE BACILLUS CALMETTE-GUERIN ON A PAPILLARY MARKER LESION OF THE BLADDERJournal of Urology, VOL. 165, NO. 2, (401-403), Online publication date: 1-Feb-2001.TAKAHASHI T, KUSHIRO A, NOMOTO K, UCHIDA K, MOROTOMI M, YOKOKURA T and AKAZA H (2018) ANTITUMOR EFFECTS OF THE INTRAVESICAL INSTILLATION OF HEAT KILLED CELLS OF THE LACTOBACILLUS CASEI STRAIN SHIROTA ON THE MURINE ORTHOTOPIC BLADDER TUMOR MBT-2Journal of Urology, VOL. 166, NO. 6, (2506-2511), Online publication date: 1-Dec-2001.MORALES A, CHIN J and RAMSEY E (2018) MYCOBACTERIAL CELL WALL EXTRACT FOR TREATMENT OF CARCINOMA IN SITU OF THE BLADDERJournal of Urology, VOL. 166, NO. 5, (1633-1638), Online publication date: 1-Nov-2001.PALOU J, LAGUNA P, MILLÁN-RODRÍGUEZ F, HALL R, SALVADOR-BAYARRI J and VICENTE-RODRÍGUEZ J (2018) CONTROL GROUP AND MAINTENANCE TREATMENT WITH BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU AND/OR HIGH GRADE BLADDER TUMORSJournal of Urology, VOL. 165, NO. 5, (1488-1491), Online publication date: 1-May-2001.DUREK C, RICHTER E, BASTECK A, RÜSCH-GERDES S, GERDES J, JOCHAM D and BÖHLE A (2018) THE FATE OF BACILLUS CALMETTE-GUERIN AFTER INTRAVESICAL INSTILLATIONJournal of Urology, VOL. 165, NO. 5, (1765-1768), Online publication date: 1-May-2001.KIM J and STEINBERG G (2018) THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, VOL. 165, NO. 3, (745-756), Online publication date: 1-Mar-2001.PEEKER R, HAGHSHENO M, HOLMÄNG S and FALL M (2018) INTRAVESICAL BACILLUS CALMETTE-GUERIN AND DIMETHYL SULFOXIDE FOR TREATMENT OF CLASSIC AND NONULCER INTERSTITIAL CYSTITIS:: A PROSPECTIVE, RANDOMIZED DOUBLE-BLIND STUDYJournal of Urology, VOL. 164, NO. 6, (1912-1916), Online publication date: 1-Dec-2000.THALMANN G, SERMIER A, RENTSCH C, MÖHRLE K, CECCHINI M and STUDER U (2018) URINARY INTERLEUKIN-8 AND 18 PREDICT THE RESPONSE OF SUPERFICIAL BLADDER CANCER TO INTRAVESICAL THERAPY WITH BACILLUS CALMETTE-GUERINJournal of Urology, VOL. 164, NO. 6, (2129-2133), Online publication date: 1-Dec-2000.AYGÜN C, ÖZEN H, KOCAGÖZ T, SARIBAŞ Z, AKI T and TEKIN i (2018) INDUCTION OF MYCOBACTEREMIA BY INTRAVESICAL BACILLUS CALMETTE-GUERIN INSTILLATION IN AN EXPERIMENTAL ANIMAL MODEL AND DETECTION WITH POLYMERASE CHAIN REACTIONJournal of Urology, VOL. 163, NO. 5, (1588-1590), Online publication date: 1-May-2000.LAMM D, BLUMENSTEIN B, CRISSMAN J, MONTIE J, GOTTESMAN J, LOWE B, SAROSDY M, BOHL R, GROSSMAN H, BECK T, LEIMERT J and CRAWFORD E (2018) MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDYJournal of Urology, VOL. 163, NO. 4, (1124-1129), Online publication date: 1-Apr-2000.LEBRET T, BOHIN D, KASSARDJIAN Z, HERVE J, MOLINIE V, BARRE P, LUGAGNE P and BOTTO H (2018) RECURRENCE, PROGRESSION AND SUCCESS IN STAGE TA GRADE 3 BLADDER TUMORS TREATED WITH LOW DOSE BACILLUS CALMETTE-GUERIN INSTILLATIONSJournal of Urology, VOL. 163, NO. 1, (63-67), Online publication date: 1-Jan-2000.LOSA A, HURLE R and LEMBO A (2018) LOW DOSE BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDER: LONG-TERM RESULTSJournal of Urology, VOL. 163, NO. 1, (68-72), Online publication date: 1-Jan-2000.ELSÄSSER-BEILE U, GUTZEIT O, BAUER S, KATZENWADEL A, SCHULTZE-SEEMANN W and WETTERAUER U (2018) SYSTEMIC AND LOCAL IMMUNOMODULATORY EFFECTS OF INTRAVESICAL BCG THERAPY IN PATIENTS WITH SUPERFICIAL URINARY BLADDER CARCINOMASJournal of Urology, VOL. 163, NO. 1, (296-299), Online publication date: 1-Jan-2000.ZHANG Y, KHOO H and ESUVARANATHAN K (2018) EFFECTS OF BACILLUS CALMETTE-GUERIN AND INTERFERON alpha-2B ON CYTOKINE PRODUCTION IN HUMAN BLADDER CANCER CELL LINESJournal of Urology, VOL. 161, NO. 3, (977-983), Online publication date: 1-Mar-1999.ALI-EL-DEIN B, NABEEH A, ISMAIL E and GHONEIM M (2018) SEQUENTIAL BACILLUS CALMETTE-GUERIN AND EPIRUBICIN VERSUS BACILLUS CALMETTE-GUERIN ALONE FOR SUPERFICIAL BLADDER TUMORS: A RANDOMIZED PROSPECTIVE STUDYJournal of Urology, VOL. 162, NO. 2, (339-342), Online publication date: 1-Aug-1999.ZLOTTA A, DROWART A, VAN VOOREN J, SHEKARSARAI H, DE COCK M, PIRSON M, PALFLIET K, JURION F, SIMON J, SCHULMAN C and HUYGEN K (2018) SUPERFICIAL BLADDER TUMORS AND INCREASED MYCOBACTERIAL BACILLUS CALMETTE-GUERIN of Urology, VOL. NO. 6, Online publication date: R, M and C (2018) AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN A OF of Urology, VOL. NO. 6, Online publication date: R, C, M, H, G, A and M (2018) OF HUMAN CELLS BY BACILLUS CALMETTE-GUERINJournal of Urology, VOL. NO. 5, Online publication date: M, H, Zhang Z, Soloway S, P and W (2018) The Treated History of High Risk Superficial Bladder Cancer: of Urology, VOL. NO. 1, Online publication date: G, B, M and U (2018) INTERLEUKIN-8 IN THE AFTER BACILLUS CALMETTE-GUERIN A PROGNOSTIC OF TUMOR AND of Urology, VOL. NO. 4, Online publication date: T, A and O'Donnell M (2018) INTRAVESICAL OF BCG AND of Urology, VOL. NO. 6, Online publication date: P, A, R, M, W and de C (2018) Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Results of for and Treatment of Cancer of Urology, VOL. NO. 4, Online publication date: B and A (2018) A of Intravesical Bacillus Calmette-Guerin and of Tumor of Urology, VOL. NO. 5, Online publication date: R, A, A, P and A (2018) Low Dose Bacillus Calmette-Guerin Regimen in Stage Grade 3 Bladder Cancer TherapyJournal of Urology, VOL. NO. 5, Online publication date: T, K, Y, H, K and K (2018) of of Intravesical Bacillus Calmette-Guerin Instillation for of Superficial Bladder CancerJournal of Urology, VOL. NO. 3, Online publication date: B, O, B, U and (2018) of and in Superficial Bladder Tumors Treated with Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 2, Online publication date: T, de E, K and D (2018) Urinary During Intravesical Bacillus Therapy for Superficial Bladder Cancer: and of Urology, VOL. NO. 2, Online publication date: D, R, D, R, E and M (2018) Intravesical Recombinant Tumor in the Treatment of Superficial Bladder Cancer: An of Urology, VOL. NO. 1, Online publication date: M, H and T (2018) Bladder Cancer: Immunotherapy in the Bladder: A Treatment Superficial Bladder CancerJournal of Urology, VOL. NO. Online publication date: M, J, H and A (2018) Intravesical Bacillus Calmette-Guerin For Superficial Bladder Cancer: Experience With of Urology, VOL. NO. 1, Online publication date: D, W, J, E, M and Liu B (2018) Bacillus Calmette-Guérin with the of for Antitumor of Urology, VOL. NO. 4, Online publication date: R, W, M and T (2018) of the Tumor-Free for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, VOL. NO. 2 1, Online publication date: M (2018) Intravesical Therapy for Bladder CancerJournal of Urology, VOL. NO. 2 1, Online publication date: Y, Y, M and (2018) Antitumor Effect of Bacillus Calmette-Guérin in with on Urinary Bladder of Urology, VOL. NO. 5, Online publication date: T, J, J, G and W (2018) for Intravesical BCG Immunotherapy for Bladder CancerJournal of Urology, VOL. NO. 3, Online publication date: J, W and Thomas C (2018) 3 after Instillation of Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 1, Online publication date: J, G and J (2018) Bacillus Calmette-Guerin Therapy for Urinary Carcinoma in of Urology, VOL. NO. 3, Online publication date: M (2018) of Urology, VOL. NO. 3, Online publication date: J, D, N, Benson D and R (2018) as A of Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, VOL. NO. 3, Online publication date: M, H, A, E, G and H (2018) Intravesical Bacillus Calmette-Guerin Immunoprophylaxis of Superficial Bladder Cancer: Results of a Controlled Trial with Treatment of Urology, VOL. NO. 4, Online publication date: M and M (2018) Management of Stage T1 Superficial Bladder Cancer with Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, VOL. NO. 3 1, Online publication date: J, B and M (2018) Complications of Intravesical Bacillus A of Urology, VOL. NO. 6, Online publication date: A, D, K, A, P, H and D (2018) Clinical of of Bacillus Long-Term Bacillus Calmette-Guerin After Intravesical Therapy for Bladder Cancer and of Urology, VOL. NO. 6, Online publication date: G, M and P (2018) Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder CancerJournal of Urology, VOL. NO. 2, Online publication date: J, C, M and J (2018) Following Intravesical Bacillus Treatment With of Urology, VOL. NO. 3 1, Online publication date: A, J and J (2018) of Bacillus Calmette-Guerin in the Treatment of Superficial Bladder CancerJournal of Urology, VOL. NO. 5, Online publication date: H (2018) of Urology, VOL. NO. 5, Online publication date: S, A, K, S, J and G (2018) The Effects of Interferon on the of Bladder Cancer CellsJournal of Urology, VOL. NO. 5, Online publication date: D (2018) of Urology, VOL. NO. 5, Online publication date: F, P, C, A, D and A (2018) A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer of Urology, VOL. NO. 1, Online publication date: K, H, T, T, A, K, T and (2018) Treatment of Bladder TumorsJournal of Urology, VOL. NO. 6, Online publication date: M, S, M, M, C and P (2018) Tumor The Effect of Bacillus on Cell of Treated and TumorsJournal of Urology, VOL. NO. 6, Online publication date: C, N, J and (2018) or Intravesical Bacillus Calmette-Guerin Immunoprophylaxis in Bladder CarcinomaJournal of Urology, VOL. NO. 3, Online publication date: W, T, and R (2018) A Intravesical Drug for the of Urology, VOL. NO. 3, Online publication date: D, J, J and M (2018) Randomized of Intravesical with Bacillus Calmette-Guerin Versus Intravesical Bacillus Calmette-Guerin in Superficial Bladder CancerJournal of Urology, VOL. NO. 4, Online publication date: (2018) by of Urology, VOL. NO. 3, Online publication date: A, J, A, A and H (2018) Effects of Bacillus Calmette-Guerin Therapy in Patients with Bladder Carcinoma on of the Bladder of Urology, VOL. NO. 1, Online publication date: A, C, A, J, J, A and H (2018) of and Tumor in the of Patients after Intravesical Bacillus Calmette-Guerin of Urology, VOL. NO. 1, Online publication date: D, M, J, T and W (2018) Long-Term of Patients Treated With 1 or 2, of Intravesical Bacillus Analysis of Predictors of of of Urology, VOL. NO. 3, Online publication date: M, J, W and T (2018) of on Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder TumorsJournal of Urology, VOL. NO. 6, Online publication date: H, H, S, T and T (2018) The of in Urinary Bladder Treated with of Urology, VOL. NO. 6, Online publication date: J, M, J, and A (2018) Clinical of Killer in Patients with Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. NO. 1, Online publication date: J, J, L, L, J, J, M and P (2018) Bacillus Calmette-Guerin Versus Versus A Randomized Study in Patients with Superficial Bladder CancerJournal of Urology, VOL. NO. 3, Online publication date: P, H, M, W, V, H and W (2018) The of Patients with Superficial Bladder Cancer to a of Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 4, Online publication date: T (2018) of Urology, VOL. NO. 4, Online publication date: M and Lamm D (2018) Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, VOL. NO. 3, Online publication date: H (2018) of Urology, VOL. NO. 3, Online publication date: M, W, J, J, E and T (2018) of an for Intravesical Bacillus Calmette-Guerin of Urology, VOL. NO. 6, Online publication date: P, H, W, R, M, J, H, M and W (2018) Intravesical Bacillus Calmette-Guerin Therapy for in Transitional Cell Carcinoma the of Urology, VOL. NO. 4, Online publication date: D (2018) of Urology, VOL. NO. 4, Online publication date: R, I and (2018) Following Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 5, Online publication date: H, H, S, T and T (2018) of Tissue in Bladder TumorsJournal of Urology, VOL. NO. 6, Online publication date: M (2018) of Urology, VOL. NO. 4, Online publication date: E, M, V, C and M (2018) and Bacillus Calmette-Guerin Immunotherapy of Recurrent Superficial Bladder of Urology, VOL. NO. 3, Online publication date: J, B, H and R (2018) and Killer of Murine Transitional Cell Carcinoma to of Urology, VOL. NO. 3, Online publication date: R, M, M and M (2018) Following Bacillus Calmette-Guerin Immunotherapy of Bladder CancerJournal of Urology, VOL. NO. 4, Online publication date: H, H, S, T and T (2018) of Tissue in Bladder TumorsJournal of Urology, VOL. NO. 4, Online publication date: R, and P (2018) Superficial Transitional Cell Carcinoma of the Bladder Associated with of the Results of Treatment with Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 2, Online publication date: H (2018) of Urology, VOL. NO. 2, Online publication date: L, R, D, M, E, S, T and W (2018) Results of Intravesical Bacillus Calmette-Guerin on the Treatment of Superficial Bladder TumorsJournal of Urology, VOL. NO. 5, Online publication date: R, L, W and T (2018) in Patients Treated with Intravesical Bacillus Calmette-Guerin for Superficial Bladder CancerJournal of Urology, VOL. NO. 5, Online publication date: H and W (2018) Carcinoma in Situ After Intravesical Therapy for Superficial Bladder and of Urology, VOL. NO. 2, Online publication date: W (2018) of Urology, VOL. NO. 2, Online publication date: M, T, D, E, S and W (2018) Versus Maintenance Bacillus Calmette-Guerin Therapy for Superficial Bladder A Randomized of Urology, VOL. NO. 2, Online publication date: J (2018) of Urology, VOL. NO. 2, Online publication date: and (2018) Intravesical Bacillus Calmette-Guerin in the Treatment of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. NO. 2, Online publication date: H, and W (2018) An of Intravesical Therapy for Superficial Bladder TumorsJournal of Urology, VOL. NO. 6, Online publication date: K, J, G and J (2018) in of Bladder Cancer by Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 1, Online publication date: G, W, G and (2018) Stage Grade 3 Transitional Cell Carcinoma of the Bladder: An of Urology, VOL. NO. 1, Online publication date: P, and A (2018) 2 and Bacillus Calmette-Guerin for Treatment of Bladder Cancer: A of Urology, VOL. NO. 2, Online publication date: C, R, J, G and B (2018) of Intravesical Immunotherapy with and in of Murine Bladder CancerJournal of Urology, VOL. NO. 2, Online publication date: H, R, E, T and M (2018) P A Bladder Carcinoma for of Urology, VOL. NO. 4, Online publication date: M and A (2018) Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Bladder in Patients have Mitomycin of Urology, VOL. NO. 5, Online publication date: W (2018) of Urology, VOL. NO. 5, Online publication date: K, G, R and A (2018) of Bladder Cancer in Treated with Intravesical Bacillus and of Urology, VOL. NO. 6, Online publication date: (2018) by of Urology, VOL. NO. 2, Online publication date: D (2018) of Urology, VOL. NO. 2, Online publication date: (2018) by of Urology, VOL. NO. 2, Online publication date: B, J, C, G, D and R (2018) of Immunotherapy with and in of Murine Transitional Cell CarcinomaJournal of Urology, VOL. NO. 3, Online publication date: E, S, T and W (2018) of Intravesical Bacillus Calmette-Guerin for Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. NO. 4, Online publication date: D (2018) of Urology, VOL. NO. 4, Online publication date: E, W and T (2018) of 2 in the of Patients with Superficial Bladder Tumors after Treatment with Intravesical of Urology, VOL. NO. 4, Online publication date: I and (2018) Treatment for Invasive Carcinoma of the BladderJournal of Urology, VOL. NO. 6, Online publication date: A and A (2018) and Therapy of an Bladder Cancer with of Urology, VOL. NO. 1, Online publication date: P, and M (2018) Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. NO. 2, Online publication date: D, E, M, J, W, S, W and T (2018) Value of Purified Protein Derivative and in Patients Treated with Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 2, Online publication date: M (2018) Bacillus Calmette-Guerin in the Management of Bladder CancerJournal of Urology, VOL. NO. 2, Online publication date: T, M and A (2018) Intravesical Bacillus Calmette-Guerin Therapy and Associated of Urology, VOL. NO. 2, Online publication date: J, W, D, T and W (2018) and in the of Bladder in Bacillus Calmette-Guerin Treatment of Superficial Bladder CancerJournal of Urology, VOL. NO. 5, Online publication date: S (2018) The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in of Urology, VOL. NO. 1, Online publication date: D (2018) Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, VOL. NO. 1, Online publication date: W (2018) of Urology, VOL. NO. 1, Online publication date: D, T, W, A, J, W, E and S (2018) Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin on Treatment of Urology, VOL. NO. 1, Online publication date: H, U and A (2018) and Human Bladder Carcinoma of Urology, VOL. NO. 3, Online publication date: M (2018) Immunotherapy in of Urology, VOL. NO. 1, Online publication date: J, M, A, R and J (2018) The Management of Superficial Bladder Tumors and Carcinoma in with Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. NO. 4, Online publication date: L, J, R, C, H, F, H, and M (2018) Intravesical Bacillus Calmette-guerin Treatment of Bladder Carcinoma with of Urology, VOL. NO. 5, Online publication date: W (2018) of Urology, VOL. NO. 5, Online publication date: A (2018) Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder CancerJournal of Urology, VOL. NO. 3, Online publication date: D and Lamm D (2018) in Bladder Cancer Following of Urology, VOL. NO. 3, Online publication date: and G (2018) Bacillus Calmette-Guerin Immunotherapy of Bladder CancerJournal of Urology, VOL. NO. 4, Online publication date: D (2018) of Urology, VOL. NO. 4, Online publication date: M (2018) of Urology, VOL. NO. 4, Online publication date: A, T, D and W (2018) of the Efficacy of Intravesical Bacillus Calmette-Guérin with Mitomycin C, and in Murine Bladder CancerJournal of Urology, VOL. NO. 1, Online publication date: R (2018) Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, VOL. NO. 3, Online publication date: and G (2018) A of Treatment for the of Recurrent Superficial Bladder TumorsJournal of Urology, VOL. NO. 1, Online publication date: A (2018) of Urology, VOL. NO. 1, Online publication date: (2018) by of Urology, VOL. NO. 1, Online publication date: M, E, V, C and P (2018) A Study of the Intravesical and BCG Treatment of Bladder CancerJournal of Urology, VOL. NO. 6, Online publication date: J (2018) of Urology, VOL. NO. 1, Online publication date: S (2018) Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, VOL. NO. 1, Online publication date: A, D, W and T (2018) Immunotherapy of Superficial Bladder CancerJournal of Urology, VOL. NO. 5, Online publication date: D, D, and H (2018) Bladder Cancer of Urology, VOL. NO. 5, (931-935), Online publication date: D, D, S and R (2018) Immunotherapy of Murine Transitional Cell CarcinomaJournal of Urology, VOL. NO. 5, Online publication date: (2018) by of Urology, VOL. NO. 2, Online publication date: A and Morales A (2018) Immunoprophylaxis of a Murine Bladder Cancer with High Dose of Urology, VOL. NO. 5, Online publication date: A and Morales A (2018) BCG Murine a Bladder Tumor Cell of Urology, VOL. NO. 6, Online publication date: A, P and (2018) Treatment of Bladder Cancer with Bacillus Calmette-guerinJournal of Urology, VOL. NO. 5, Online publication date: D, D, S, J, and H (2018) Bacillus Calmette-guerin Immunotherapy of Superficial Bladder CancerJournal of Urology, VOL. NO. 1, Online publication date: M (2018) Bladder of Urology, VOL. NO. 1, Online publication date: M (2018) for Intravesical for Superficial Bladder CancerJournal of Urology, VOL. NO. 4, Online publication date: S, K, K and K (2018) of A in Treatment of Bladder CarcinomaJournal of Urology, VOL. NO. 4, Online publication date: M (2018) Bladder Cancer: to the of Urology, VOL. NO. 4, Online publication date: H (2018) Current Therapy of Bladder CarcinomaJournal of Urology, VOL. NO. 1, Online publication date: M, J, R and J (2018) Instillation of in the Treatment of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 118, NO. 5, Online publication date: 1976 by The American Urological Association Education and Research, A. Morales Current address: Laboratory of Immunodiagnosis, Building 8, Room 118, National Institutes of Health, Bethesda, Maryland, 20014. More articles by this author D. Eidinger More articles by this author A.W. Bruce More articles by this author All